|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.45 CNY | -0.53% |
|
-3.62% | -23.59% |
| 10/04 | Lanzhou Foci Pharmaceutical Chairman Resigns | MT |
| 10/04 | Lanzhou Foci Pharmaceutical Co.,Ltd. Proposes Final Cash Dividend for the Year 2023 | CI |
LanZhou Foci Pharmaceutical Co.,Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 809.39 million compared to CNY 659.96 million a year ago. Net income was CNY 93.26 million compared to CNY 108.02 million a year ago.
Basic earnings per share from continuing operations was CNY 0.1826 compared to CNY 0.2115 a year ago. Diluted earnings per share from continuing operations was CNY 0.1826 compared to CNY 0.2115 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -23.59% | 528M | |
| +37.65% | 6.11B | |
| -19.68% | 4.33B | |
| +4.49% | 3.22B | |
| -15.69% | 2.96B | |
| -5.64% | 2.42B | |
| +44.89% | 1.92B | |
| -12.71% | 1.61B | |
| -4.27% | 1.57B | |
| -14.86% | 1.51B |
LANZHOU FOCI PHARMACEUTICAL CO.,LTD. 
